Iladek 3 3 mg Tablet
PDF Leaflet Revision Date: 10 Aug 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of gastrointestinal strongyloidiasis, lymphatic filariasis, human sarcoptic scabies, and onchocerciasis.
Dosage (summary)
200 mcg/kg as a single oral dose; specific dosing based on body weight for mass distribution.
Special Populations
- Immunocompromised patients
- Paediatric patients < 15 kg
Pregnancy & Breastfeeding
Safety in pregnancy not established; limited data show no adverse effects in first trimester. Use in breastfeeding only after one week postpartum.
Key Drug Interactions
- Diethylcarbamazine citrate (DEC) not recommended with ivermectin
Contraindications
- Hypersensitivity to ivermectin or excipients
Common side effects
- Transient hypereosinophilia
- Liver dysfunction
- Nausea
- Dizziness
- Pruritus
Counselling Points
- Take on an empty stomach with water
- Avoid food 2 hours before/after administration
- Monitor for adverse reactions
Serious warnings
- Risk of serious adverse reactions in patients co-infected with Loa loa
- Not a prophylactic therapy
Important Disclaimer
The Iladek 3 3 mg Tablet professional information leaflet below is the property of Trinity Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
